Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 8968658)

1.

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Riva R, Albani F, Contin M, Baruzzi A.

Clin Pharmacokinet. 1996 Dec;31(6):470-93. Review.

PMID:
8968658
2.

Cognitive Adverse Effects of Antiepileptic Drugs : Incidence, Mechanisms and Therapeutic Implications.

Kälviäinen R, Äikiä M, Riekkinen PJ Sr.

CNS Drugs. 1996 May;5(5):358-68. doi: 10.2165/00023210-199605050-00005.

PMID:
26071048
3.

Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients.

Bourgeois FT, Olson KL, Poduri A, Mandl KD.

Paediatr Drugs. 2015 Jun 13. [Epub ahead of print]

PMID:
26070280
4.

Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels.

Ekstein D, Tirosh M, Eyal Y, Eyal S.

Epilepsy Behav. 2015 Mar;44:218-24. doi: 10.1016/j.yebeh.2015.02.009. Epub 2015 Mar 12.

PMID:
25771206
5.

The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part I: A summary of the current state for clinicians.

de Leon J.

Rev Psiquiatr Salud Ment. 2015 Apr-Jun;8(2):97-115. doi: 10.1016/j.rpsm.2014.10.006. Epub 2015 Mar 3. English, Spanish.

6.

Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs.

Zaccara G, Perucca E.

Epileptic Disord. 2014 Dec;16(4):409-31. doi: 10.1684/epd.2014.0714. Review.

PMID:
25515681
7.

Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants.

Italiano D, Spina E, de Leon J.

Expert Opin Drug Metab Toxicol. 2014 Nov;10(11):1457-89. doi: 10.1517/17425255.2014.956081. Epub 2014 Sep 6. Review.

PMID:
25196459
8.

Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy.

Yamamoto Y, Takahashi Y, Imai K, Takahashi M, Nakai M, Inoue Y, Kagawa Y.

Eur J Clin Pharmacol. 2014 Oct;70(10):1203-10. doi: 10.1007/s00228-014-1719-5. Epub 2014 Jul 22.

PMID:
25048408
9.

Treatment of hypopituitarism in patients receiving antiepileptic drugs.

Paragliola RM, Prete A, Kaplan PW, Corsello SM, Salvatori R.

Lancet Diabetes Endocrinol. 2015 Feb;3(2):132-40. doi: 10.1016/S2213-8587(14)70081-6. Epub 2014 Jun 2.

PMID:
24898833
10.

Decreased efficacy of an etonogestrel implant in a woman on antiepileptic medications: a case report.

Lange J, Teal S, Tocce K.

J Med Case Rep. 2014 Feb 11;8:43. doi: 10.1186/1752-1947-8-43.

11.
12.

Use of antiepileptic drugs in hepatic and renal disease.

Asconapé JJ.

Handb Clin Neurol. 2014;119:417-32. doi: 10.1016/B978-0-7020-4086-3.00027-8. Review.

PMID:
24365310
13.
14.

The interaction potential of retigabine (ezogabine) with other antiepileptic drugs.

Tompson DJ, Crean CS.

Curr Clin Pharmacol. 2014 May;9(2):148-56. Review.

PMID:
24219007
15.

Clinically significant drug interactions with atypical antipsychotics.

Kennedy WK, Jann MW, Kutscher EC.

CNS Drugs. 2013 Dec;27(12):1021-48. doi: 10.1007/s40263-013-0114-6. Review.

PMID:
24170642
16.

Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.

Anderson GD, Hakimian S.

Clin Pharmacokinet. 2014 Jan;53(1):29-49. Review.

PMID:
24122696
17.

Perioperative substitution of anti-epileptic drugs.

Wichards WS, Schobben AF, Leijten FS.

J Neurol. 2013 Nov;260(11):2865-75. doi: 10.1007/s00415-013-7067-z. Epub 2013 Sep 1. Review.

PMID:
23996127
18.

Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.

Patsalos PN.

Clin Pharmacokinet. 2013 Nov;52(11):927-66. doi: 10.1007/s40262-013-0087-0. Review.

PMID:
23784470
19.

Therapeutic drug monitoring of antiepileptic drugs by use of saliva.

Patsalos PN, Berry DJ.

Ther Drug Monit. 2013 Feb;35(1):4-29. doi: 10.1097/FTD.0b013e31827c11e7. Review.

PMID:
23288091
20.

Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide.

Antel J, Hebebrand J.

Handb Exp Pharmacol. 2012;(209):433-66. doi: 10.1007/978-3-642-24716-3_20. Review.

PMID:
22249827
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk